EyePoint Pharmaceuticals
EYPT
#5226
Rank
C$2.04 B
Marketcap
C$24.69
Share price
0.45%
Change (1 day)
97.21%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : C$0.28 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has C$0.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.53 B21.22%
2023-12-31C$0.43 B123.84%
2022-12-31C$0.19 B-27.24%
2021-12-31C$0.26 B370.85%
2020-12-31C$57.26 M97.37%
2019-12-31C$29.01 M
2018-06-30C$50.98 M132.28%
2017-06-30C$21.95 M-41.57%
2016-06-30C$37.56 M5.52%
2015-06-30C$35.6 M82.54%
2014-06-30C$19.5 M80.59%
2013-06-30C$10.8 M-27.2%
2012-06-30C$14.83 M-36.2%
2011-06-30C$23.25 M25.05%
2010-06-30C$18.59 M134.59%
2009-06-30C$7.92 M-50.15%
2008-06-30C$15.9 M461.8%
2007-06-30C$2.83 M-77.77%
2006-06-30C$12.73 M4.78%
2005-06-30C$12.15 M-58.11%
2004-06-30C$29 M2616.46%
2003-06-30C$1.06 M
2001-06-30C$2.48 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
C$3.07 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
C$0.18 M-99.94% Bahamas